IN2015DN01616A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN01616A IN2015DN01616A IN1616DEN2015A IN2015DN01616A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A IN 1616DEN2015 A IN1616DEN2015 A IN 1616DEN2015A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A
- Authority
- IN
- India
- Prior art keywords
- tissue
- cells
- cell formulation
- myocardial
- pluripotent stem
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012181029 | 2012-08-17 | ||
PCT/JP2013/054049 WO2014027474A1 (ja) | 2012-08-17 | 2013-02-19 | 心筋梗塞の修復再生を誘導する多能性幹細胞 |
PCT/JP2013/071981 WO2014027684A1 (ja) | 2012-08-17 | 2013-08-15 | 心筋梗塞の修復再生を誘導する多能性幹細胞 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN01616A true IN2015DN01616A (es) | 2015-07-03 |
Family
ID=50685515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1616DEN2015 IN2015DN01616A (es) | 2012-08-17 | 2013-08-15 |
Country Status (14)
Country | Link |
---|---|
US (3) | US9844570B2 (es) |
EP (2) | EP3659612B1 (es) |
JP (1) | JP5968442B2 (es) |
KR (1) | KR101730052B1 (es) |
CN (1) | CN104582711B (es) |
AU (1) | AU2013303492B2 (es) |
CA (1) | CA2882239C (es) |
DK (1) | DK2886123T3 (es) |
ES (1) | ES2767182T3 (es) |
IN (1) | IN2015DN01616A (es) |
PL (1) | PL2886123T3 (es) |
PT (1) | PT2886123T (es) |
SG (2) | SG11201501185WA (es) |
WO (2) | WO2014027474A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014027474A1 (ja) | 2012-08-17 | 2014-02-20 | 株式会社Clio | 心筋梗塞の修復再生を誘導する多能性幹細胞 |
JP2015160820A (ja) * | 2014-02-26 | 2015-09-07 | 株式会社Clio | 慢性腎障害治療のための多能性幹細胞 |
JP6452107B2 (ja) | 2014-09-05 | 2019-01-16 | 国立大学法人 東京大学 | 糖尿病性皮膚潰瘍治療のための多能性幹細胞 |
WO2016168993A1 (en) | 2015-04-22 | 2016-10-27 | Innolife Co., Ltd. | Methods of tissue repair and regeneration |
JP6770673B2 (ja) * | 2016-02-26 | 2020-10-21 | 国立大学法人東海国立大学機構 | 急性心筋梗塞の予後マーカー及びその利用 |
SG11201811806TA (en) * | 2016-07-01 | 2019-02-27 | Univ Tohoku | Prophylactic or therapeutic agent for organ fibrosis |
WO2018021515A1 (ja) * | 2016-07-29 | 2018-02-01 | 国立大学法人東北大学 | 血管障害の予防又は治療剤 |
EP3495471A4 (en) | 2016-08-03 | 2020-02-19 | Life Science Institute, Inc. | METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN VITRO |
CA3032925A1 (en) * | 2016-08-03 | 2018-02-08 | Life Science Institute, Inc. | Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells |
EP3494978A4 (en) * | 2016-08-03 | 2020-03-11 | National University Corporation Nagoya University | IMPROVEMENT AND TREATMENT OF CHRONIC PULMONARY DISEASES USING PLURIPOTENT STEM CELLS |
CN106822899B (zh) * | 2017-03-10 | 2020-11-27 | 北京大学 | 一种通过抑制自噬促进心肌再生的药物 |
AU2018352904A1 (en) * | 2017-10-17 | 2020-05-21 | Hiroshima University | Pluripotent stem cells inducing osteochondral repair |
JP7102666B2 (ja) * | 2018-01-25 | 2022-07-20 | 国立大学法人東海国立大学機構 | Muse細胞動員剤及び心筋障害への利用 |
JP7072777B2 (ja) * | 2018-07-03 | 2022-05-23 | 株式会社生命科学インスティテュート | 慢性腎障害治療のための多能性幹細胞 |
CN110302212A (zh) * | 2019-07-17 | 2019-10-08 | 陶正博 | 一种用于治疗急性心肌梗死的细胞制剂及其制备方法 |
US20220218744A1 (en) | 2019-08-19 | 2022-07-14 | Cellaxia Inc. | Cell-containing pharmaceutical composition |
US20220323509A1 (en) * | 2019-09-05 | 2022-10-13 | Tohoku University | Therapeutic agent for myocarditis |
CA3156700A1 (en) * | 2019-10-31 | 2021-05-06 | Life Science Institute, Inc. | Therapy for interstitial cystitis by pluripotent stem cells |
US20230203436A1 (en) | 2020-04-02 | 2023-06-29 | Tohoku University | High-potential pluripotent stem cells |
JP2021073305A (ja) * | 2021-02-09 | 2021-05-13 | 株式会社生命科学インスティテュート | 慢性腎障害治療のための多能性幹細胞 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000484A1 (en) * | 1992-06-22 | 1994-01-06 | Young Henry E | Scar inhibitory factor and use thereof |
AU8401498A (en) * | 1997-07-14 | 1999-02-10 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
BR9912662A (pt) * | 1998-07-31 | 2001-06-05 | Genzyme Corp | Melhoria de função cardìaca por transplante de célula de ramo mesenquimal |
US20020061587A1 (en) | 2000-07-31 | 2002-05-23 | Piero Anversa | Methods and compositions for the repair and/or regeneration of damaged myocardium |
WO2002057430A2 (en) * | 2001-01-20 | 2002-07-25 | Cardion Ag | Pluripotent adult stem cells derived from regenerative tissue |
AU2002313670C1 (en) | 2001-07-12 | 2009-08-06 | Asterias Biotherapeutics, Inc. | Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
US9782439B2 (en) | 2005-01-27 | 2017-10-10 | Japan Health Sciences Foundation | Cell sheet containing mesenchymal stem cells |
EP2208786B1 (en) | 2005-12-13 | 2018-08-01 | Kyoto University | Nuclear reprogramming factor |
CN101517069A (zh) * | 2006-07-13 | 2009-08-26 | 塞拉帝思股份公司 | 由人类胚泡来源的干细胞衍生的多能心脏前体细胞新种群 |
WO2009046058A1 (en) | 2007-10-01 | 2009-04-09 | University Of Miami | A method to amplify cardiac stem cells in vitro and in vivo |
JP5394932B2 (ja) | 2007-11-02 | 2014-01-22 | 日本ケミカルリサーチ株式会社 | ヒト間葉系幹細胞含有医薬組成物 |
JP5564679B2 (ja) * | 2009-04-16 | 2014-07-30 | 公益財団法人ヒューマンサイエンス振興財団 | 心筋細胞分化誘導促進剤およびその使用方法 |
US9550975B2 (en) * | 2009-07-15 | 2017-01-24 | Mari Dezawa | SSEA-3 pluripotent stem cell isolated from body tissue |
EP2630234B1 (en) * | 2010-10-18 | 2017-12-13 | Sunshine Biotech Inc. | Human multipotent embryonic stem cell-like progenitor cells |
WO2014027474A1 (ja) | 2012-08-17 | 2014-02-20 | 株式会社Clio | 心筋梗塞の修復再生を誘導する多能性幹細胞 |
-
2013
- 2013-02-19 WO PCT/JP2013/054049 patent/WO2014027474A1/ja active Application Filing
- 2013-08-15 DK DK13879518.2T patent/DK2886123T3/da active
- 2013-08-15 IN IN1616DEN2015 patent/IN2015DN01616A/en unknown
- 2013-08-15 PL PL13879518T patent/PL2886123T3/pl unknown
- 2013-08-15 US US14/421,754 patent/US9844570B2/en active Active
- 2013-08-15 EP EP19202650.8A patent/EP3659612B1/en active Active
- 2013-08-15 CN CN201380043649.5A patent/CN104582711B/zh active Active
- 2013-08-15 CA CA2882239A patent/CA2882239C/en active Active
- 2013-08-15 PT PT138795182T patent/PT2886123T/pt unknown
- 2013-08-15 WO PCT/JP2013/071981 patent/WO2014027684A1/ja active Application Filing
- 2013-08-15 KR KR1020157006629A patent/KR101730052B1/ko active IP Right Grant
- 2013-08-15 JP JP2014530568A patent/JP5968442B2/ja active Active
- 2013-08-15 ES ES13879518T patent/ES2767182T3/es active Active
- 2013-08-15 EP EP13879518.2A patent/EP2886123B1/en active Active
- 2013-08-15 AU AU2013303492A patent/AU2013303492B2/en not_active Ceased
- 2013-08-15 SG SG11201501185WA patent/SG11201501185WA/en unknown
- 2013-08-15 SG SG10201800829XA patent/SG10201800829XA/en unknown
-
2017
- 2017-11-03 US US15/802,899 patent/US10376544B2/en active Active
-
2019
- 2019-06-25 US US16/452,376 patent/US10639335B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104582711B (zh) | 2019-12-06 |
AU2013303492B2 (en) | 2017-02-16 |
US9844570B2 (en) | 2017-12-19 |
CA2882239C (en) | 2018-05-22 |
EP2886123B1 (en) | 2019-10-23 |
KR101730052B1 (ko) | 2017-04-25 |
US20180050067A1 (en) | 2018-02-22 |
SG11201501185WA (en) | 2015-05-28 |
PT2886123T (pt) | 2020-01-22 |
EP3659612B1 (en) | 2023-06-07 |
KR20150043482A (ko) | 2015-04-22 |
CA2882239A1 (en) | 2014-02-20 |
DK2886123T3 (da) | 2020-01-27 |
WO2014027474A1 (ja) | 2014-02-20 |
SG10201800829XA (en) | 2018-03-28 |
US20190307806A1 (en) | 2019-10-10 |
EP2886123A1 (en) | 2015-06-24 |
EP2886123A4 (en) | 2016-06-22 |
AU2013303492A1 (en) | 2015-03-12 |
EP3659612A1 (en) | 2020-06-03 |
US10639335B2 (en) | 2020-05-05 |
JPWO2014027684A1 (ja) | 2016-07-28 |
CN104582711A (zh) | 2015-04-29 |
PL2886123T3 (pl) | 2020-05-18 |
ES2767182T3 (es) | 2020-06-16 |
US20150196600A1 (en) | 2015-07-16 |
US10376544B2 (en) | 2019-08-13 |
JP5968442B2 (ja) | 2016-08-10 |
WO2014027684A1 (ja) | 2014-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015DN01616A (es) | ||
NZ623454A (en) | Pharmaceutical composition for the treatment of heart diseases | |
MX2016005574A (es) | Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel. | |
BR112014010776A8 (pt) | neurônios dopaminérgicos (da) mesencefálicos para enxerto | |
AU2009240884A8 (en) | Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation | |
MX340276B (es) | Metodos, sistema y aparato para la deteccion, diagnostico y tratamiento de trastornos del ritmo biologico. | |
ES2721180T3 (es) | Productos terapéuticos usando células adiposas y secreciones celulares | |
MX340185B (es) | Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca. | |
ES2572211T3 (es) | Regeneración de músculo esquelético utilizando células madre mesenquimales | |
WO2012106367A3 (en) | Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease | |
JP2014509319A5 (es) | ||
WO2014183033A3 (en) | G-csf for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal | |
EA201490995A1 (ru) | Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток | |
SG11201900986YA (en) | Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells | |
CA2904533C (en) | Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells | |
Gui-xian et al. | Therapeutic effects of umbilical cord mesenchymal stem cells transplantation on systemic lupus erythematosus | |
WO2014072720A3 (en) | Cell differentiation | |
SG11201810188VA (en) | Amelioration and treatment of perinatal brain damage with pluripotent stem cells | |
SG11201900983TA (en) | Amelioration and treatment of chronic lung disease using pluripotent stem cells | |
WO2012169897A8 (en) | Weight reducing material | |
WO2014063035A3 (en) | Treatment of pain using amnion derived adherent cells | |
UA100881U (uk) | Засіб для відновлення уражених тканин організму людини | |
PL418104A1 (pl) | Sposób odnowy tkankowej z wykorzystaniem komórek regenerujących | |
Karataeva et al. | THE MONITORING ORGANIZATION OF THE INDIVIDUAL REHABILITATION PROGRAMS IMPLEMENTATION EFFECTIVENESS IN NIZHNY NOVGOROD REGION | |
Tuman | Sinus bradycardia: case report |